Roberta L. Buell is a Principal at onPoint Oncology Inc., specializing in oncology reimbursement. With over 23 years of experience in billing, coding, and drug therapy reimbursement, she's a nationally recognized expert and frequent speaker on regulatory and reimbursement issues. Bobbi has led more than 600 seminars since 1991 and currently serves as content director for focalPoint® and assistPoint®. Learn more about Bobbi here .
CAR-T billing hits community oncology: learn 2025 coding rules, fractional billing, modifiers KX, LU, 76, and new CAR-T admin code 38228. Key tips for Part B claims.
CMS proposes 2026 Medicare Advantage and Part D changes, including payment increases, risk model updates, and Part D reforms under the Inflation Reduction Act.
Get the latest Q1 2025 OPPS drug updates from CMS, including new pass-throughs, deletions, payment changes, and status indicators effective January 1, 2025.
The American Relief Act extends key Medicare telehealth flexibilities through March 31, 2025—but fails to fix physician pay cuts. Read the full 2025 update.
No articles match your search.
The Comparative Report puts ASP, the Medicare payment limit, WAC and AWP for up to 15 drugs on one timeline. Ten-plus years of monthly history, per HCPCS unit.
Included with BuyandBill Pro for $37/month billed annually.
Trastuzumab class, seven products
Actual published ASP, Jan 2015 to Aug 2026.
